• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

YAP/TAZ 的过度激活通过稳定糖尿病肾病中的 N-Myc 驱动系膜细胞的改变。

Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy.

机构信息

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

Center for Vascular Research, Institute for Basic Science, Daejeon, Republic of Korea.

出版信息

J Am Soc Nephrol. 2023 May 1;34(5):809-828. doi: 10.1681/ASN.0000000000000075. Epub 2023 Jan 21.

DOI:10.1681/ASN.0000000000000075
PMID:36724799
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10125647/
Abstract

SIGNIFICANCE STATEMENT

Mesangial cells (MCs) in the kidney are essential to maintaining glomerular integrity, and their impairment leads to major glomerular diseases including diabetic nephropathy (DN). Although high blood glucose elicits abnormal alterations in MCs, the underlying mechanism is poorly understood. We show that YAP/TAZ are increased in MCs of patients with DN and two animal models of DN. High glucose directly induces activation of YAP/TAZ through the canonical Hippo pathway in cultured MCs. Hyperactivation of YAP/TAZ in mouse MCs recapitulates the hallmarks of DN. Activated YAP/TAZ bind and stabilize N-Myc, one of the Myc family. N-Myc stabilization leads to aberrant enhancement of its transcriptional activity and to MC impairments. Our findings shed light on how high blood glucose in diabetes mellitus leads to DN and support a rationale that lowering blood glucose in diabetes mellitus could delay DN pathogenesis.

BACKGROUND

Mesangial cells (MCs) in the kidney are central to maintaining glomerular integrity, and their impairment leads to major glomerular diseases, including diabetic nephropathy (DN). Although high blood glucose elicits abnormal alterations in MCs, the underlying molecular mechanism is poorly understood.

METHODS

Immunolocalization of YAP/TAZ and pathological features of PDGFRβ + MCs were analyzed in the glomeruli of patients with DN, in Zucker diabetic fatty rats, and in Lats1/2i ΔPβ mice. RiboTag bulk-RNA sequencing and transcriptomic analysis of gene expression profiles of the isolated MCs from control and Lats1/2iΔPβ mice were performed. Immunoprecipitation analysis and protein stability of N-Myc were performed by the standard protocols.

RESULTS

YAP and TAZ, the final effectors of the Hippo pathway, are highly increased in MCs of patients with DN and in Zucker diabetic fatty rats. Moreover, high glucose directly induces activation of YAP/TAZ through the canonical Hippo pathway in cultured MCs. Hyperactivation of YAP/TAZ in mouse model MCs recapitulates the hallmarks of DN, including excessive proliferation of MCs and extracellular matrix deposition, endothelial cell impairment, glomerular sclerosis, albuminuria, and reduced glomerular filtration rate. Mechanistically, activated YAP/TAZ bind and stabilize N-Myc protein, one of the Myc family of oncogenes. N-Myc stabilization leads to aberrant enhancement of its transcriptional activity and eventually to MC impairments and DN pathogenesis.

CONCLUSIONS

Our findings shed light on how high blood glucose in diabetes mellitus leads to DN and support a rationale that lowering blood glucose in diabetes mellitus could delay DN pathogenesis.

摘要

研究意义

肾脏中的系膜细胞(MCs)对于维持肾小球完整性至关重要,其损伤会导致包括糖尿病肾病(DN)在内的主要肾小球疾病。尽管高血糖会引起 MCs 的异常改变,但其中的潜在机制尚不清楚。我们发现,DN 患者和两种 DN 动物模型的 MCs 中 YAP/TAZ 增加。高葡萄糖在培养的 MCs 中通过经典 Hippo 通路直接诱导 YAP/TAZ 的激活。在小鼠 MCs 中过度激活 YAP/TAZ 可重现 DN 的特征。激活的 YAP/TAZ 结合并稳定 N-Myc,即 Myc 家族的一种。N-Myc 的稳定导致其转录活性的异常增强,从而导致 MCs 损伤。我们的研究结果阐明了糖尿病中高血糖如何导致 DN,并支持了降低糖尿病中血糖水平可能延缓 DN 发病机制的观点。

研究背景

肾脏中的系膜细胞(MCs)对于维持肾小球完整性至关重要,其损伤会导致包括糖尿病肾病(DN)在内的主要肾小球疾病。尽管高血糖会引起 MCs 的异常改变,但其中的潜在分子机制尚不清楚。

研究方法

通过免疫组化分析 DN 患者、Zucker 糖尿病肥胖大鼠和 Lats1/2iΔPβ 小鼠肾小球中的 YAP/TAZ 和 PDGFRβ+MC 的病理特征。对来自对照和 Lats1/2iΔPβ 小鼠的分离 MC 进行核糖体标签批量 RNA 测序和基因表达谱的转录组分析。通过标准方案进行 N-Myc 的免疫沉淀分析和蛋白质稳定性分析。

研究结果

Hippo 通路的最终效应物 YAP 和 TAZ 在 DN 患者和 Zucker 糖尿病肥胖大鼠的 MCs 中高度增加。此外,高葡萄糖在培养的 MCs 中通过经典 Hippo 通路直接诱导 YAP/TAZ 的激活。在小鼠模型 MCs 中过度激活 YAP/TAZ 可重现 DN 的特征,包括 MCs 的过度增殖和细胞外基质沉积、内皮细胞损伤、肾小球硬化、白蛋白尿和肾小球滤过率降低。在机制上,激活的 YAP/TAZ 结合并稳定 N-Myc 蛋白,即 Myc 家族的一种致癌基因。N-Myc 的稳定导致其转录活性的异常增强,最终导致 MCs 损伤和 DN 发病机制。

研究结论

我们的研究结果阐明了糖尿病中高血糖如何导致 DN,并支持了降低糖尿病中血糖水平可能延缓 DN 发病机制的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b8e/10125647/3beb8475d66f/jasn-34-809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b8e/10125647/3beb8475d66f/jasn-34-809-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b8e/10125647/3beb8475d66f/jasn-34-809-g001.jpg

相似文献

1
Hyperactivation of YAP/TAZ Drives Alterations in Mesangial Cells through Stabilization of N-Myc in Diabetic Nephropathy.YAP/TAZ 的过度激活通过稳定糖尿病肾病中的 N-Myc 驱动系膜细胞的改变。
J Am Soc Nephrol. 2023 May 1;34(5):809-828. doi: 10.1681/ASN.0000000000000075. Epub 2023 Jan 21.
2
Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway.槲皮素通过 Hippo 通路抑制早期糖尿病肾病系膜细胞增殖。
Pharmacol Res. 2019 Aug;146:104320. doi: 10.1016/j.phrs.2019.104320. Epub 2019 Jun 17.
3
YAP mediates the interaction between the Hippo and PI3K/Akt pathways in mesangial cell proliferation in diabetic nephropathy.YAP 介导 Hippo 和 PI3K/Akt 通路在糖尿病肾病系膜细胞增殖中的相互作用。
Acta Diabetol. 2021 Jan;58(1):47-62. doi: 10.1007/s00592-020-01582-w. Epub 2020 Aug 20.
4
Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy.Sestrin2 通过调控 Hippo 通路减轻糖尿病肾病肾损伤。
Cell Tissue Res. 2022 Oct;390(1):93-112. doi: 10.1007/s00441-022-03668-z. Epub 2022 Jul 12.
5
Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.糖尿病(OLETF)大鼠系膜细胞对低密度脂蛋白和血管紧张素II的反应。
Kidney Int. 2002 Jan;61(1):113-24. doi: 10.1046/j.1523-1755.2002.00107.x.
6
Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.糖尿病大鼠和小鼠模型、体外肾小球系膜细胞和糖尿病肾病患者中肾和循环 Nop-7 相关蛋白 2(NSA2)水平升高。
Diabetologia. 2012 Mar;55(3):825-34. doi: 10.1007/s00125-011-2373-4. Epub 2011 Nov 18.
7
Proximal tubule-derived exosomes contribute to mesangial cell injury in diabetic nephropathy via miR-92a-1-5p transfer.近端肾小管来源的外泌体通过 miR-92a-1-5p 转移促进糖尿病肾病系膜细胞损伤。
Cell Commun Signal. 2023 Jan 13;21(1):10. doi: 10.1186/s12964-022-00997-y.
8
Targeting mammalian serine/threonine-protein kinase 4 through Yes-associated protein/TEA domain transcription factor-mediated epithelial-mesenchymal transition ameliorates diabetic nephropathy orchestrated renal fibrosis.通过 Yes 相关蛋白/TEA 结构域转录因子介导的上皮间质转化靶向哺乳动物丝氨酸/苏氨酸蛋白激酶 4可改善糖尿病肾病介导的肾纤维化。
Metabolism. 2020 Jul;108:154258. doi: 10.1016/j.metabol.2020.154258. Epub 2020 May 3.
9
The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.mTOR 促进糖尿病肾病中氧化应激诱导的系膜细胞凋亡。
Mol Cell Endocrinol. 2018 Sep 15;473:31-43. doi: 10.1016/j.mce.2017.12.012. Epub 2017 Dec 24.
10
MUC1 Promotes Mesangial Cell Proliferation and Kidney Fibrosis in Diabetic Nephropathy Through Activating STAT and β-Catenin Signal Pathway.MUC1通过激活STAT和β-连环蛋白信号通路促进糖尿病肾病中系膜细胞增殖和肾纤维化。
DNA Cell Biol. 2021 Oct;40(10):1308-1316. doi: 10.1089/dna.2021.0098. Epub 2021 Sep 14.

引用本文的文献

1
Mesangial Cells in Diabetic Kidney Disease: From Mechanisms to Therapeutic Implications.糖尿病肾病中的系膜细胞:从发病机制到治疗意义
Int J Biol Sci. 2025 Jul 24;21(11):4762-4781. doi: 10.7150/ijbs.114907. eCollection 2025.
2
The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy.YAP/TAZ在糖尿病心肌病发展中的机械作用
Curr Issues Mol Biol. 2025 Apr 23;47(5):297. doi: 10.3390/cimb47050297.
3
The Role of Yes-Associated Protein in Inflammatory Diseases and Cancer.Yes相关蛋白在炎症性疾病和癌症中的作用。
MedComm (2020). 2025 Mar 10;6(3):e70128. doi: 10.1002/mco2.70128. eCollection 2025 Mar.
4
GABP Promotes Mesangial Cell Proliferation and Renal Fibrosis Through GLI1 in Diabetic Nephropathy.在糖尿病肾病中,GABP通过GLI1促进系膜细胞增殖和肾纤维化。
Adv Sci (Weinh). 2025 Apr;12(15):e2407462. doi: 10.1002/advs.202407462. Epub 2025 Feb 22.
5
Activation of MST1 protects filtration barrier integrity of diabetic kidney disease in mice through restoring the tight junctions of glomerular endothelial cells.MST1的激活通过恢复肾小球内皮细胞的紧密连接来保护小鼠糖尿病肾病的滤过屏障完整性。
Acta Pharmacol Sin. 2025 May;46(5):1345-1360. doi: 10.1038/s41401-024-01421-6. Epub 2024 Dec 6.
6
YAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease.YAP1维持肾小管线粒体质量控制以减轻糖尿病肾病。
Redox Biol. 2024 Dec;78:103435. doi: 10.1016/j.redox.2024.103435. Epub 2024 Nov 23.
7
Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway.细胞质 HMGB1 在系膜细胞中的积累通过 NFκB 信号通路加重糖尿病肾病的进展。
Cell Mol Life Sci. 2024 Sep 17;81(1):408. doi: 10.1007/s00018-024-05433-7.
8
Glutaminolysis is a Potential Therapeutic Target for Kidney Diseases.谷氨酰胺分解是肾脏疾病的一个潜在治疗靶点。
Diabetes Metab Syndr Obes. 2024 Jul 23;17:2789-2807. doi: 10.2147/DMSO.S471711. eCollection 2024.
9
Knockout of C1q/tumor necrosis factor-related protein-9 aggravates cardiac fibrosis in diabetic mice by regulating YAP-mediated autophagy.敲除C1q/肿瘤坏死因子相关蛋白9通过调节YAP介导的自噬加重糖尿病小鼠的心脏纤维化。
Front Pharmacol. 2024 Jul 8;15:1407883. doi: 10.3389/fphar.2024.1407883. eCollection 2024.
10
LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease.LRG1 缺失可有效抑制肾小球 TGF-β 信号转导,从而减轻糖尿病肾病。
Mol Ther. 2024 Sep 4;32(9):3177-3193. doi: 10.1016/j.ymthe.2024.06.027. Epub 2024 Jun 22.